Michelle Tarver
Tracked across 2 events · 28 articles · First seen Jun 13, 2026 · Last active Aug 27, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Michelle Tarver, director of the United States — Food and Drug Administration's Center for Devices and Radiological Health, commented on the importance of the clearance for pediatric patients.
Jun 13, 2026 · 7 articles
Regulatory
The U.S. United States — Food and Drug Administration (FDA) authorized the Aletta, the first standalone robotic device that can autonomously draw blood from a patient's arm. The device, made by Dutch medical robotics company…
Impact: As FDA's Center for Devices and Radiological Health director, Tarver announced the authorization, highlighting the agency's commitment to addressing public health needs.
Aug 19, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Michelle Tarver live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard